incid
decreas
week
progress
refractori
hypoxia
major
caus
death
follow
multiorgan
failur
shock
shock
signific
latter
part
diseas
cours
organ
failur
seen
kidney
liver
bone
marrow
epidem
hospit
patient
need
intens
care
unit
icu
admiss
comorbid
note
patient
admit
icu
includ
obes
copd
diabet
mellitu
asthma
immunosuppress
chronic
kidney
diseas
heart
failur
overal
icu
mortal
rate
critic
ill
patient
close
factor
independ
associ
mortal
includ
requir
invas
mechan
ventil
imv
low
pao
fio
icu
admiss
presenc
comorbid
older
age
autopsi
fi
nding
show
three
distinct
pulmonari
patholog
diffus
alveolar
damag
dad
necrot
bronchiol
dad
alveolar
hemorrhag
invas
mechan
ventil
lungprotect
ventilatori
strategi
fl
uid
restrict
recommend
initi
approach
manag
patient
pandem
infect
complic
ard
noninvas
mechan
ventil
nimv
use
fi
rstline
therapi
small
number
patient
deterior
subsequ
need
imv
guidelin
endors
european
respiratori
societi
er
european
societi
intens
care
medicin
esicm
state
nimv
consid
altern
imv
patient
acut
hypoxem
respiratori
failur
secondari
infect
like
progress
ard
reason
nimv
use
fi
rstline
therapi
respiratori
failur
follow
poor
clinic
effi
caci
sever
respiratori
failur
rapidli
progress
refractori
hypoxemia
ard
patient
present
almost
uniformli
hypoxem
respiratori
failur
hypercapn
respiratori
failur
great
concern
aerosol
droplet
particl
dispers
spread
infect
indic
nimv
patient
infect
follow
earli
stage
mild
respiratori
failur
character
minim
pulmonari
infi
ltrate
pao
fio
mild
moder
hypercapn
respiratori
failur
exacerb
copd
relat
infect
postextub
respiratori
failur
due
resolv
ard
wean
prolong
mechan
ventil
patient
cardiogen
edema
absenc
pneumonia
multiorgan
failur
refractori
hypoxemia
addit
requir
nimv
negativepressur
wellventil
room
bacteri
viral
fi
lter
expiratori
circuit
recommend
regard
nimv
risk
aerosol
droplet
infect
mainli
base
studi
publish
experi
follow
sever
acut
respiratori
syndrom
sar
epidem
tabl
pivot
studi
argu
nimv
pose
high
risk
infect
spread
base
assess
particl
dispers
use
experiment
model
smoke
introduc
lung
mannequin
noninvas
ventil
niv
use
plume
smoke
emerg
vent
mask
photograph
particl
dispers
far
studi
conduct
evalu
particl
dispers
human
whether
mannequin
simul
live
patient
use
nimv
greatli
debat
mani
argu
nimv
mask
may
fact
offer
protect
secret
would
otherwis
dispers
infect
patient
cough
sneez
speak
also
compar
data
particl
dispers
individu
undergo
nimv
sar
outbreak
studi
hong
kong
look
effi
caci
nimv
earli
ard
patient
also
evalu
infect
risk
among
hcw
direct
contact
patient
nimv
patient
need
nimv
hcw
includ
doctor
nurs
healthcar
assist
expos
patient
nimv
therapi
regularli
screen
sign
infect
coronaviru
serolog
obtain
hcw
nimv
equip
expiratori
bacteri
viral
fi
lter
provid
isol
cubicl
ward
icu
central
aircondit
fi
tted
exhaust
ventil
fan
achiev
negativepressur
fl
ow
studi
conclud
nimv
effect
prevent
imv
patient
acut
respiratori
failur
due
sar
effect
reduc
icu
length
stay
avoid
icu
admiss
altogeth
moreov
infect
note
hcw
serolog
test
coronaviru
neg
base
guidelin
ersesicm
world
health
organ
unit
kingdom
nation
health
servic
agenc
hong
kong
lung
foundat
american
associ
respiratori
care
nimv
current
consid
highrisk
procedur
respiratori
pandem
led
icu
overus
strain
avail
resourc
increas
imvrel
complic
valid
associ
nimv
infect
spread
particl
dispers
need
plan
futur
pandem
noninvas
mechan
ventil
role
manag
earli
respiratori
failur
due
infect
strictli
control
environ
close
monitor
hcw
nimv
role
patient
sever
respiratori
failur
ard
relat
sever
infect
patient
must
intub
place
imv
howev
much
still
debat
potenti
risk
particl
dispers
spread
infect
due
nimv
present
